<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5007572 Figure_1-A</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Representative results of Western blot analysis of RAD21, E-cadherin, and VIM are shown for luminal and basal-like breast cancer cell lines. The images were analyzed using ImageJ (National Institutes of Health, USA). Protein levels from the Western blots were quantified and normalized relative to &#945;-tubulin. Bars represent the mean &#177; S.D for four independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_1-B</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunofluorescence staining for VIM (green) or E-cadherin (green) and RAD21 (red) in a panel of MCF7 or HCC1143 cells.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_1-C</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) The level of RAD21 mRNA in breast cancer cell lines. Values were normalized relative to 18S transcription. The plotted data are the average for three independent experiments. Bars represent the mean &#177; S.D.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_1-D</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Stabilities of the RAD21 transcript and protein in MCF7 or HCC1143 cells. Cells were treated with 10 &#181;g/mL actinomycin D for 0, 3, 6, 9, 12, and 24 h, after which total RNA and proteins were extracted. c-Myc and 18S were used as the controls.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_2-A</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) qPCR was conduced to measure the expression of RAD21. The indicated cells were stably transduced with control GFP-shRNA or two different RAD21-specific shRNA (shR#1 or shR#2, day 30). Data are presented as the mean &#177; S.D. for three independent experiments *P &lt; 0.01 and; **P &lt; 0.05. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_2-B</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Results of the Western blot analysis for RAD21, E-cadherin, and VIM in RAD21KD- MCF7, -T47D, -SNU16, and -SNU620cells are presented.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_2-C</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) qPCR was performed to measure the expression of EMT markers ZEB2, CDH2, ZEB1, FN1, TWIST, and SNAIL2 in RAD21KD-MCF7 (upper graph) or -SNU16 cells (lower graph). Data are presented as the mean &#177; S.D. for three independent experiments *P &lt; 0.01 and; **P &lt; 0.05. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_2-D</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Up-regulated genes by RAD21KD (shR#1) in MCF7 or SNU16 cells, each of which showed more than a 2-fold change in RAD21KD cells compared to the shCont.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_2-E</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Induction of TGFB1 and ITGA5 transcription in RAD21KD-MCF7, -T47D, -SNU16, and -SNU620 cells was evaluated using qPCR. Data are presented as the mean &#177; S.D. for three independent experiments. *P &lt; 0.01. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_2-F</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Expression of TGFB1 and ITGA5 mRNA normalized to the 18S transcript in luminal and basal-like breast cancer cell lines, E: epithelial-like, M: mesenchymal-like breast cancer cell lines. Data are presented as the mean &#177; S.D. for three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_3-A</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Imaging of RAD21KD-MCF7 and -SNU16 cells to assess cell morphology. Depletion of RAD21 caused a conversion from an epithelial-like to fibroblast-like morphology.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_3-B-C</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 3-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Immunofluorescence staining for (B) VIM and (C) &#946;-catenin in RAD21KD-SNU16 cells. The indicated cells were immunostained with antibody specific for VIM or &#946;-catenin, and DAPI. Each image represents three individual experiments.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_3-D</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Western blots for EMT-markers TGFBR1, TGFBR2, TGFB1, ITGA5, and &#946;-catenin in RAD21KD-MCF7 and -SNU16 cells.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_3-E</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Stable transfection of RAD21 shRNA in MCF7 cancer cells increased migration capabilities revealed by a wound-healing assay. Wound size was measured at 0, 24, and 48 h to calculate open wound rate (%). Data are presented as the means &#177; S.D. for three independent experiments. *P &lt; 0.01 and; **P &lt; 0.05. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_3-F-I</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 3-F-I</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F-I</infon>
    <passage>
      <offset>0</offset>
      <text>qPCR was performed to measure the expression of EMT markers VIM, ZEB2, CDH2, ZEB1, and FN1 along with the epithelial marker CDH1 in (F, G) shR#1_MCF7 or (H, J) shR#1_SNU16 cells after transfection with 20nM negative control, TGFB1 (siTGFB1#3 and siTGFB1#4) or ITGA5 (siITGA5#1 and siITGA5#2) siRNA for 48 h. Values were normalized relative to 18S transcription. Gene expression values in the samples were divided by those in the controls (i.e. each gene in the control is '1'). Data are presented as the means &#177; S.D. for three independent experiments *P &lt; 0.01. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_4-A-B-C</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 4-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>TGFB1 and ITGA5 loci on chromosome 19q13.2 and chromosome 12q13.13, respectively. The location of putative CTCF binding sites and representative amplicon sites used for qPCR are shown with names below. A ChIP assay was performed for RAD21KD-MCF7 or -SNU16 cells using antibodies specific for (A) RAD21, (B) Pol II, (C) AcH3, or IgG (as a control). Enrichment was measured by qPCR and expressed relative to the total input (4%). ChIP signals for AcH3 were normalized to total H3. Results for at least three chromatin preparations are shown &#177; S.E.M. *P &lt; 0.01, **P &lt; 0.05. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_4-D-E</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 4-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>Relative crosslinking frequencies among CTCF/RAD21 binding sites on the genes were measured with a 3C assay in the control GFP-shRNA (blue line) or RAD21KD (red line) -MCF7 or -SNU16 cells on day 30 after lentiviral transduction. (D) BamH1 or (E) Xba I restriction sites on the TGFB1 or ITGA5 gene, respectively, appear as gray shaded bars. Black shading indicates the anchor fragment. Each value was normalized to crosslinking frequency at the ERCC3 gene. The maximum crosslinking frequency was set at 1. (means &#177; S.E.M, n = 3). *P &lt; 0.01, **P &lt; 0.05. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_5-A</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>RAD21 and EMT-related molecules in parent MDA-MB-453breast cancer cells (P) and the corresponding CSLCs (indicated by CSC or CSLC) sorted according to the CD44+ cancer stem cell markers were observed by (A) qPCR. Data are presented as the mean &#177; S.D. for three independent experiments. *P &lt; 0.01. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_5-B</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>RAD21 and EMT-related molecules in parent MDA-MB-453 breast cancer cells (P) and the corresponding CSLCs (indicated by CSC or CSLC) sorted according to the CD44+ cancer stem cell markers were observed by (B) Western blot analysis. Data are presented as the mean &#177; S.D. for three independent experiments. *P &lt; 0.01. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_5-C</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Cell migration assay of MDA-MB-453 parental and CSCL cells using Transwell chamber without matrigel. Graphs indicate the average number of cells per field. *P &lt; 0.01. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_5-D</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Relative crosslinking frequencies among CTCF/RAD21 binding sites on the genes were measured with a 3C assay in the parental cells (blue line) or CSLCs (red line). BamH1 or Xba I restriction sites on the TGFB1or ITGA5 gene, respectively, appear as gray shaded bars. Black shading indicates the anchor fragment. Each value was normalized to the crosslinking frequency at the ERCC3 gene. The maximum crosslinking frequency was set at 1 (mean &#177; S.E.M, n = 3). *P &lt; 0.01, **P &lt;0.05. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_5-E</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) A ChIP assay was performed for the CSLCs (red bar) or parental cells (blue bar) using antibodies specific for RAD21, AcH3, Pol II, or IgG (as the control). Enrichment was measured by qPCR and reported relative to the total input (4%). ChIP signals for AcH3 was normalized to total H3. Results for at least three chromatin preparations are shown &#177; S.E.M. *P &lt; 0.01, **P &lt;0.05. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_6-A</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) The relative mRNA expression levels of EMT-related genes in RAD21-overexpressing MDA-MB-231 cells were quantified and normalized by 18s transcript. Empty vector-expressing MDA-MB-231 control cells are indicated by 231_P; RAD21-expressing MDA-MB-231 cells are indicated by 231_R. The data shown are the mean &#177; S.D. for three independent experiments. *P &lt; 0.01, **P &lt; 0.05. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_6-B</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Western blots for RAD21 in RAD21-overexpressing MDA-MB-231 cells.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_6-C</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) A ChIP assay was performed for RAD21-overexpressing MDA-MB-231 and the empty vector expressing cells using antibodies specific for RAD21, Pol II, and H3K9ac, or IgG (as a control). Enrichment was measured by qPCR and expressed relative to the total input (4%). ChIP signals for H3K9ac were normalized to total H3. Results for at least three chromatin preparations are shown &#177; S.E.M. *P &lt; 0.01, **P &lt; 0.05. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
  <document>
    <id>5007572 Figure_6-D</id>
    <infon key="sourcedata_document">2111</infon>
    <infon key="doi">10.15252/embr.201541852</infon>
    <infon key="pmc_id">5007572</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Relative crosslinking frequencies among CTCF/RAD21 binding sites on the genes were measured with a 3C assay in the control (blue line) or RAD21-overexpressing (red line) MDA-MB-231 cells on day 10 after lentiviral transduction. BamH1 or XbaI restriction sites on the TGFB1 or ITGA5 gene, respectively, appear as gray shaded bars. Black shading indicates the anchor fragment. Each value was normalized to crosslinking frequency at the ERCC3 gene. The maximum crosslinking frequency was set at 1. (means &#177; S.E.M, n = 3). *P &lt; 0.01, **P &lt; 0.05. Statistical significance was validated by Student's t-tests.</text>
    </passage>
  </document>
</collection>
